Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival
post lung transplantation. Given the clinical heterogeneity of CLAD, recently two phenotypes …

Thoracic surgery has evolved drastically in recent years. Although thoracic surgeons mainly
deal with tumorous lesion in the lungs, mediastinum, and pleura, they also perform lung …

Introduction Lung transplantation has proven to be an effective treatment option for end‐
stage lung disease. However, early and late complications following transplantation remain …

BACKGROUND Long-term survival after lung transplantation (LTx) is hampered by chronic
lung allograft dysfunction (CLAD). Our study evaluated the prevalence and prognostic …

Pirfenidone may attenuate the decline of pulmonary function in restrictive allograft syndrome
(RAS) after lung transplantation. We retrospectively assessed all lung transplant recipients …

Background Lung retransplantation (ReTx) comprises an increasing share of lung
transplants and recently has shown improved outcomes. The aim of this study was to identify …

The long‐term success of lung transplantation (LT) is limited by chronic lung allograft
dysfunction (CLAD). Different phenotypes of CLAD have been described, such as …

Restrictive subtype of chronic lung allograft dysfunction (CLAD) was recently described after
lung transplantation. This study compares different definitions of a restrictive phenotype in …

Chronic lung allograft rejection remains one of the major causes of morbi-mortality after lung
transplantation. The term Chronic Lung Allograft Dysfunction (CLAD) has been proposed to …

Introduction Chronic lung allograft dysfunction (CLAD) can take two forms: bronchiolitis
obliterans syndrome (BOS) or restrictive allograft syndrome (RAS). The aim was to …